INVESTIGATION OF PLASMID-MEDIATED AmpC BETA-LACTAMASE TYPES IN KLEBSIELLA SPP. AND ESCHERICHIA COLI ISOLATES RESISTANT OR INTERMEDIATE TO CEFOXITIN


Demirbakan H., MİDİLLİ K., Ogunc D., Özen N., ÖNGÜT G., Dağlar D., ...Daha Fazla

MIKROBIYOLOJI BULTENI, cilt.42, sa.4, ss.545-551, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 4
  • Basım Tarihi: 2008
  • Dergi Adı: MIKROBIYOLOJI BULTENI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.545-551
  • Anahtar Kelimeler: Plasmid mediated AmpC beta-lactamases, Escherichia coli, Klebsiella spp., PREVALENCE, EPIDEMIOLOGY, PNEUMONIAE, GENES
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Plasmid mediated AmpC beta-lactamases are reported from Enterobacteriaceae with increasing frequency. There have been reports of treatment failures in patients infected with these organisms and given broad-spectrum cephalosporins. The aim of this study was to investigate the presence of plasmid mediated AmpC beta-lactamases in Escherichia coli and Klebsiella spp. A total of 41 strains of cefoxitin resistant or intermediate E.coli (n= 27) and Klebsiella spp. (n= 14) were collected from January 2005 to January 2006 at Akdeniz University Hospital Central Laboratory. Three-dimensional test was used as a phenotypic confirmatory test. Analytical isoelectric focusing electrophoresis was used to measure the pl values of the beta-lactamases. Plasmid mediated AmpC enzyme genes were amplified using multiplex polymerase chain reaction and sequenced by Beckman Coulter CEQ 8000. AmpC beta-lactamases were only detected in two isolates (7.4%) of E.coli. These isolates produced CMY-2 like enzymes and have either CTX-M or TEM enzyme. Transferable AmpC beta-lactamases are associated with multiple antibiotic resistance. Therefore detection of these enzymes in gram-negative bacteria has a clinical importance, since it can often provide valuable information to clinicians leading to more effective and appropriate use of antimicrobials.